Skip to main content
HR 1504 107th Congress House Taxation AIDS (Disease) Biotechnology Business income tax Clinical trials Commerce Communicable diseases Developing countries Drug industry Economics and Public Finance Government trust funds Health Human immunodeficiency viruses Income tax International Affairs International agencies International cooperation Malaria Medical research Microbiological research

Vaccines for the New Millennium Act of 2001

Introduced: April 4, 2001 Introduced by: Pelosi, Nancy Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 25, 2001
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Apr 5, 2001
Sponsor introductory remarks on measure. (CR E554)
Apr 4, 2001
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and International Relations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 4, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Vaccines for the New Millennium Act of 2001 - Amends the Internal Revenue Code to allow a limited business credit for the costs medical research related to developing vaccines against widespread diseases. Defines widespread diseases as malaria, tuberculosis, HIV, or any infectious disease (of a single etiology) which, according to the World Health Organization, causes over one million human deaths annually.

Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.

Establishes the Lifesaving Vaccine Purchase Fund.

Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.

What's happening now April 25, 2001

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1
D
DeLauro, Rosa L.
Connecticut · Apr 4, 2001
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1504: Vaccines for the New Millennium Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-1504/
MLA
"H.R. 1504: Vaccines for the New Millennium Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-1504/.
Bluebook (legal)
H.R. 1504, 107th Cong. (2026), https://openamerica.io/bill/107-HR-1504/.
Markdown link
[H.R. 1504: Vaccines for the New Millennium Act of 2001](https://openamerica.io/bill/107-HR-1504/)
Report a problem